Search

Stories published in 2024 about UT Southwestern Medical Center.

Email Address (you@someplace.com) *Required × Error: A field is missing data or special characters were used. Please correct. Recipient Email Address (recipient@someplace.com) *Required × Error: A field is missing data or special characters were used. Please correct. × Error: A field is missing data or special characters were used. Please correct. Optional Message × Error: A field is missing data or special characters were used. Please correct. Yes! Send me news from UT Southwestern Medical

Stories published in 2025 about UT Southwestern Medical Center.

– Being pregnant during the holidays brings its own set of challenges whether you’re traveling to visit family and friends or just looking to get away.

Two UT Southwestern Medical Center researchers – a biochemist and a molecular biologist – are among 33 distinguished scientists nationwide named Howard Hughes Medical Institute (HHMI) Investigators.

Researchers at UT Southwestern Medical Center have developed a novel artificial intelligence (AI) model that analyzes the spatial arrangement of cells in tissue samples.

While the holiday season can bring joy to people of all ages, it also leaves many feeling depressed and lonely. Those who already suffer from a mental health condition can develop more serious symptoms. According to a survey by the National Alliance on Mental Illness (NAMI), 64% of people who have

The U.S. Food & Drug Administration has expanded the approved use of belzutifan for treatment of metastatic kidney cancer, another milestone for the novel, first-in-class kidney cancer drug arising from scientific discoveries at UT Southwestern Medical Center.

Despite the convenience of at-home screening tests for early detection of colorectal cancer (CRC), a study led by UT Southwestern Medical Center researchers examining more than a decade of patient data found that about 10% of the tests could not be processed, mostly due to patient error.

A two-step screening protocol that combines clinical risk assessment with biomarker testing can more effectively identify which patients with Type 2 diabetes need medication to prevent heart failure, according to a study led by UT Southwestern Medical Center researchers.